| Product Code: ETC13158404 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Personalized Medicine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Personalized Medicine Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Personalized Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 North America Personalized Medicine Market - Industry Life Cycle |
3.4 North America Personalized Medicine Market - Porter's Five Forces |
3.5 North America Personalized Medicine Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Personalized Medicine Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 North America Personalized Medicine Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
4 North America Personalized Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Personalized Medicine Market Trends |
6 North America Personalized Medicine Market, 2021 - 2031 |
6.1 North America Personalized Medicine Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Personalized Medicine Market, Revenues & Volume, By Personalized Medicine Diagnostics, 2021 - 2031 |
6.1.3 North America Personalized Medicine Market, Revenues & Volume, By Personalized Medicine Therapeutics, 2021 - 2031 |
6.1.4 North America Personalized Medicine Market, Revenues & Volume, By Personalized Medical Care, 2021 - 2031 |
6.1.5 North America Personalized Medicine Market, Revenues & Volume, By Personalized Nutrition & Wellness, 2021 - 2031 |
6.2 North America Personalized Medicine Market, Revenues & Volume, By End-Use, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Personalized Medicine Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.2.3 North America Personalized Medicine Market, Revenues & Volume, By Diagnostic Centers, 2021 - 2031 |
6.2.4 North America Personalized Medicine Market, Revenues & Volume, By Research & Academic Institutes, 2021 - 2031 |
6.2.5 North America Personalized Medicine Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Personalized Medicine Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Personalized Medicine Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.1 United States (US) Personalized Medicine Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.2 Canada Personalized Medicine Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.3 Rest of North America Personalized Medicine Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3 North America Personalized Medicine Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
7.3.1 United States (US) Personalized Medicine Market, Revenues & Volume, By End-Use, 2021 - 2031 |
7.3.2 Canada Personalized Medicine Market, Revenues & Volume, By End-Use, 2021 - 2031 |
7.3.3 Rest of North America Personalized Medicine Market, Revenues & Volume, By End-Use, 2021 - 2031 |
8 North America Personalized Medicine Market Key Performance Indicators |
9 North America Personalized Medicine Market - Export/Import By Countries Assessment |
10 North America Personalized Medicine Market - Opportunity Assessment |
10.1 North America Personalized Medicine Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Personalized Medicine Market Opportunity Assessment, By Product, 2021 & 2031F |
10.3 North America Personalized Medicine Market Opportunity Assessment, By End-Use, 2021 & 2031F |
11 North America Personalized Medicine Market - Competitive Landscape |
11.1 North America Personalized Medicine Market Revenue Share, By Companies, 2022 |
11.2 North America Personalized Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here